Lexaria Bioscience Corp. (LEXX) Fundamentals

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
SHARE INFORMATION
Market Cap$ 17,912,504
Shares Outstanding5,950,998
Float4,044,528
Percent Float67.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 255,397
Latest Fiscal EPS$ -1.25
Latest Fiscal Date2022-08-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions16
Institutional Holdings Date2021-06-30
Institutional Bought Previous 3 Months40,472
Institutional Holdings Percent8.2%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months-
Insider Holdings Percent70.3
Insider Sold Previous 3 Months-
Insider Shares Owned4,184,257
TRADING INFO
52 Week High$ 4.83
52 Week Low$ 1.80
52 Week High Change$ -21.82
21 Day Moving Average$ 2.8381
21 Day Extended Moving Average$ 2.8771
50 Day Moving Average$ 2.7277
50 Day Extended Moving Average$ 2.7298
200 Day Moving Average$ 2.6184
200 Day Extended Moving Average$ 2.8993
10 Day Average Volume20,085
20 Day Average Volume19,229
30 Day Average Volume16,450
50 Day Average Volume15,292
Alpha0.000632
Beta0.1567
Standard Deviation0.193775
R20.002008
7 Day Price Change$ 0.07
7 Day Percent Change2.38%
21 Day Price Change$ 0.24
21 Day Percent Change8.66%
30 Day Price Change$ 0.46
30 Day Percent Change18.04%
Month to Date Price Change$ -0.2001
Month to Date Percent Change-6.23%
Quarter to Date Price Change$ 0.55
Quarter to Date Percent Change22.36%
180 Day Price Change$ 0.29
180 Day Percent Change10.66%
200 Day Price Change$ 0.23
200 Day Percent Change8.27%
Year to Date Price Change$ 0.55
Year to Date Percent Change22.36%

Lexaria Bioscience Corp. (LEXX) Key Ratios

PROFITABILITY
EBIT Margin-2,084.4%
EBITDA Margin-2,044.2%
Pre-Tax Profit Margin-1,919.8%
Profit Margin Count0.0%
Gross Margin73.4%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 342,993
Revenue Per Share$ 0.0576
Revenue (3 Years)$ 1.46
Revenue (5 Years)$ 18.99
FINANCIAL STRENGTH
Price to Tangible Book3.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio19.00
Leverage Ratio1.00
Quick Ratio18.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-2.50
Enterprise Value$ 13,149,362
Price to Sales52.2241
Price to Free Cash-3.50
PE High Last 5 Years-8.10
Price To Book2.90
Price To Cash Flow29.80
PE Low Last 5 Years-8.00
Price to Tangible Book3.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.10
Invoice Turnover4.60
Assets Turnover0.00
Return Assets-80.82
Return on Equity-80.89
Return on Capital-77.83

Lexaria Bioscience Corp. (LEXX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDavidson & Company LLP
CEOChristopher Bunka
Emplyoees6
Last AuditUQ
CIK0001348362
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address740 McCurdy Road
Suite 100
Kelowna, BC V1X 2P7
Websitehttps://www.lexariabioscience.com
Facsimile-
Telephone+1 250 765-6424
Emailir@lexariabioscience.com
Your Recent History
NASDAQ
LEXX
Lexaria Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230207 23:56:32